Plasma exchange as rescue therapy in multiple organ failure including acute renal failure*
- 1 June 2003
- journal article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 31 (6) , 1730-1736
- https://doi.org/10.1097/01.ccm.0000064742.00981.14
Abstract
To describe the outcome of using a rescue therapy including plasma exchange given to patients with a progressive acute disseminated intravascular coagulation and multiple organ dysfunction syndrome. Retrospective study. University and county hospital. Included were 76 consecutive patients (41 men and 35 women) treated with plasma exchange as rescue therapy besides optimal conventional therapy during a progressive course of disseminated intravascular coagulation and multiple organ dysfunction syndrome, including acute renal failure. Of the 76 patients, 66% needed dialysis. The distribution was hemodialysis in 76%, continuous arteriovenous hemofiltration in 36%, continuous venovenous hemodialysis in 12%, and peritoneal dialysis in 24%. The median organ-failure score was 5 (range, 1-6). Seventy-two percent required mechanical ventilation; septic shock was present in 88%. The median septic shock score was 4 (range, 2-4). Nine patients had another reason than sepsis for the multiple organ dysfunction syndrome. Plasma exchange (centrifugation technique) was performed until disseminated intravascular coagulation was reversed (median, two times; range, 1-14). Besides antibiotics and fluid administration, most patients received heparin or low molecular weight heparin (77%), steroids (87%), and inotropes (88%). More than one vasoactive drug was used in 57% of the patients. Eighty-two percent of the patients survived and could leave the hospital. The previously observed survival rates by others for this category of patients would be <20%, and thus, the outcome in this study is significantly better. Plasma exchange using plasma as replacement may, in addition to conventional intensive care, help to reverse severe progressive disseminated intravascular coagulation and multiple organ dysfunction syndrome and improve survival.Keywords
This publication has 36 references indexed in Scilit:
- The presence of superantigens and complex host responses in severe sepsis may need a broad therapeutic approach.Therapeutic Apheresis and Dialysis, 2001
- Is There a Future for Adsorption Techniques in Sepsis?Blood Purification, 2000
- A Novel Acute-Phase Marker: Lipopolysaccharide Binding Protein (LBP)cclm, 1999
- Pharmacokinetics, immunogenicity, and efficacy of dimeric TNFR binding proteins in healthy and bacteremic baboonJournal of Applied Physiology, 1998
- Effect of soluble P55 tumour‐necrosis factor binding fusion protein on the local Shwartzman and Arthus reactionsBritish Journal of Pharmacology, 1996
- Functional comparisons of different tumour necrosis factor receptor/IgG fusion proteinsCytokine, 1995
- Multiple Organ Dysfunction ScoreCritical Care Medicine, 1995
- Bacterial endotoxin: molecular relationships of structure to activity and functionThe FASEB Journal, 1994
- Monoclonal antibodies to soluble human TNF receptor (TNF binding protein) enhance its ability to block TNF toxicityCytokine, 1992
- Etiology of Multiple Organ FailurePublished by Wolters Kluwer Health ,1990